Affiliation:
1. Shree S.K. Patel College of Pharmaceutical Education and Research, Mahesana, Gujarat, India
2. Smt.S.M.Shah Pharmacy College, Aamsaran, Gujarat, India
Abstract
The goal of this study is to create a mouth-melting strip of L-methyl folate calcium, which will dissolve and disintegrate more quickly when given orally for the onset of action. : Solvent casting was used to create a calcium L-methyl folate film that dissolves in the mouth. Polymer, plasticizer, and flavouring agents were chosen after early experiments. Once the excipients were chosen, 3 complete factorial designs were used to improve the formulation. Folding endurance (Y1), tensile strength (Y2), and disintegration time (Y3) were chosen as dependent variables, whereas HPMC E5 concentration (X1) and glycerine concentration (X2) were chosen as independent variables. The film's physicochemical parameters, including SEM, thickness, percent elongation, percent cumulative drug release, and palatability, were measured for the optimized batch and compared to those of the commercial product. The formulation of the mouth-dissolving strip took into account outcomes from the trial batch, including transparency, stickiness, and brittleness. The optimal batch has 55% HPMC E5 and 14.9% glycerine, with a folding endurance of 59±0.23, a tensile strength of 4.18±0.07 N/m, and a disintegration time of 40±0.12 seconds. The optimized film has dimensions of 0.08±0.01 mm in thickness, 60±1.58 mg in mass, 15.33±0.25% in elongation, and 98.33±0.27% in content uniformity. The SEM results validate the uniform film with uniform drug distribution. After 3 minutes, the L-methyl folate calcium mouth-dissolving strip had a %CDR of 99.42%. Findings of f2=52.85 and f1=12.5 for the similarity factor suggest that the medication release is clinically and commercially equivalent. One month of stability at 30°C and 65%RH was observed for the improved batch. The results of the created mouth-dissolving strip test are satisfactory, indicating the intended medication release. When compared to pills that dissolve in the mouth, it is clear that it is more patient-friendly.
Publisher
IP Innovative Publication Pvt Ltd
Subject
Industrial and Manufacturing Engineering,Environmental Engineering
Reference16 articles.
1. Lindgren S, Janzon L, Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population.Dysphagia 1991;6(4):187-92
2. Sefidani FA, Lau ETL, Steadman KJ, Kyle GJ, Cichero JAY, Santos JMS, Appropriateness of oral dosage form modification for aged care residents: a video-recorded observational study.Int J Clin Pharm 2020;42(3):938-47
3. Comoglu T, Dilek OE, Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.Pharm Dev Technol 2019;24(7):902-14
4. Rathbone MJ, Drummond BK, Tucker IG, The oral cavity as a site for systemic drug delivery.Adv drug deli rev 1994;13(1-2):1-22
5. Sheikh FA, Aamir MN, Shah MA, Ali L, Anwer K, Javaid Z, Formulation design, characterization and in vitro drug release study of orodispersible film comprising BCS class II drugs.Pak J Pharm Sci 2020;33(Supplementary):343-53